新型透明质酸填充剂VYC-25L非手术鼻整形:鼻部网格法应用结果
该回顾性单中心分析纳入61例接受VYC-25L注射的成人患者,采用已发表的网格方案指导注射量与顺序,随访6至9个月。治疗后2周独立评估显示所有患者VAS评分达9或10分,97%患者自评矫正充分,3个月和6个月随访结果稳定,并发症包括瘀斑25%、不对称3%和血肿2%,均快速消退,无感染、结节或皮肤坏死。
要点
- VYC-25L用于非手术鼻整形安全有效,患者满意度高。
- 网格法可指导注射量与顺序,治疗后2周矫正效果显著。
- 常见并发症为瘀斑,无感染、结节或皮肤坏死等严重不良事件。
核心结论
- VYC-25L用于鼻部治疗安全有效,患者满意度高,有潜力成为非手术鼻整形的有价值工具。
研究设计与样本
- 回顾性单中心分析,纳入2019年2月至4月接受VYC-25L鼻部治疗的成年患者,以网格系统为注射量和顺序的参考,随访6至9个月。
主要发现
- 共纳入61例患者,平均年龄32±3岁,女性45例(74%)。
- 治疗后2周独立评估确认高度缺陷矫正,所有患者在10分视觉模拟量表上评分为9或10分。
- 结果在3个月和6个月随访时保持稳定。
- 记录的并发症包括瘀斑(n=15,25%)、不对称(n=2,3%)和血肿(n=1,2%),均快速消退。
临床怎么用
- 可参考网格法进行VYC-25L鼻部注射,以指导注射量和顺序。
- 治疗时需注意瘀斑、不对称和血肿等并发症的预防与处理。
局限性
- 回顾性单中心设计可能限制结果的普遍性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nonsurgical aesthetic treatment of the nose is becoming increasingly popular. VYC-25L is a novel hyaluronic acid product with the high G' and cohesivity required of a nasal filler. OBJECTIVES: The authors sought to assess the safety and efficacy of VYC-25L for treatment of the nose utilizing a previously published, grid-based protocol. METHODS: This was a retrospective, single-center analysis of data from adult patients undergoing treatment of the nose with VYC-25L between February and April 2019 utilizing the grid system as the reference for injection quantity and sequencing. Specific procedures included correction of inadequate projection, deep glabella treatment, correction of a nasal hump, and adjustment of the nasolabial angle and columella. Patients were followed-up for 6 to 9 months. RESULTS: A total of 61 patients were included in the analysis (mean age, 32 ± 3 years; n = 45 females [74%]). At 2 weeks posttreatment, a high degree of defect correction was confirmed based on independent evaluation, with all patients scoring 9 or 10 on a 10-point visual analog scale. Fifty-nine of 61 patients (97%) self-assessed the degree of correction as "adequate." Results were stable at 3- and 6-month follow-up visits. Complications recorded were bruising (n = 15, 25%), asymmetry (n = 2, 3%), and hematoma (n = 1, 2%). All resolved rapidly. There were no cases of infection, bumps, or skin necrosis. CONCLUSIONS: VYC-25L is safe and efficacious for treatment of the nose, with high levels of patient satisfaction. It has potential to be a valuable tool in nonsurgical rhinoplasty.
引用
- Bertossi D, Malchiodi L, Albanese M, et al. Nonsurgical Rhinoplasty With the Novel Hyaluronic Acid Filler VYC-25L: Results Using a Nasal Grid Approach. Aesthet Surg J. 2021. PMID: 32628267. doi:10.1093/asj/sjaa196
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。